BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8422404)

  • 1. Orientation and structure of the NH2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes.
    Martin I; Defrise-Quertain F; Decroly E; Vandenbranden M; Brasseur R; Ruysschaert JM
    Biochim Biophys Acta; 1993 Jan; 1145(1):124-33. PubMed ID: 8422404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusogenic activity of SIV (simian immunodeficiency virus) peptides located in the GP32 NH2 terminal domain.
    Martin I; Defrise-Quertain F; Mandieau V; Nielsen NM; Saermark T; Burny A; Brasseur R; Ruysschaert JM; Vandenbranden M
    Biochem Biophys Res Commun; 1991 Mar; 175(3):872-9. PubMed ID: 2025261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidylcholine mediates the mode of insertion of the NH2-terminal SIV fusion peptide into the lipid bilayer.
    Martin I; Dubois MC; Saermark T; Epand RM; Ruysschaert JM
    FEBS Lett; 1993 Nov; 333(3):325-30. PubMed ID: 8224203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and orientation study of fusion peptide FP23 of gp41 from HIV-1 alone or inserted into various lipid membrane models (mono-, bi- and multibi-layers) by FT-IR spectroscopies and Brewster angle microscopy.
    Castano S; Desbat B
    Biochim Biophys Acta; 2005 Sep; 1715(2):81-95. PubMed ID: 16126160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between fusogenicity of synthetic modified peptides corresponding to the NH2-terminal extremity of simian immunodeficiency virus gp32 and their mode of insertion into the lipid bilayer: an infrared spectroscopy study.
    Martin I; Dubois MC; Defrise-Quertain F; Saermark T; Burny A; Brasseur R; Ruysschaert JM
    J Virol; 1994 Feb; 68(2):1139-48. PubMed ID: 8289343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer.
    Martin I; Schaal H; Scheid A; Ruysschaert JM
    J Virol; 1996 Jan; 70(1):298-304. PubMed ID: 8523539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects.
    Pereira FB; Goñi FM; Muga A; Nieva JL
    Biophys J; 1997 Oct; 73(4):1977-86. PubMed ID: 9336193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational mapping of the N-terminal peptide of HIV-1 gp41 in lipid detergent and aqueous environments using 13C-enhanced Fourier transform infrared spectroscopy.
    Gordon LM; Mobley PW; Lee W; Eskandari S; Kaznessis YN; Sherman MA; Waring AJ
    Protein Sci; 2004 Apr; 13(4):1012-30. PubMed ID: 15044732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion.
    Pritsker M; Jones P; Blumenthal R; Shai Y
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7287-92. PubMed ID: 9636141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational mapping of the N-terminal peptide of HIV-1 gp41 in membrane environments using (13)C-enhanced Fourier transform infrared spectroscopy.
    Gordon LM; Mobley PW; Pilpa R; Sherman MA; Waring AJ
    Biochim Biophys Acta; 2002 Feb; 1559(2):96-120. PubMed ID: 11853678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The polar region consecutive to the HIV fusion peptide participates in membrane fusion.
    Peisajovich SG; Epand RF; Pritsker M; Shai Y; Epand RM
    Biochemistry; 2000 Feb; 39(7):1826-33. PubMed ID: 10677233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The helix-to-sheet transition of an HIV-1 fusion peptide derivative changes the mechanical properties of lipid bilayer membranes.
    Heller WT; Zolnierczuk PA
    Biochim Biophys Acta Biomembr; 2019 Mar; 1861(3):565-572. PubMed ID: 30550881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-state nuclear magnetic resonance measurements of HIV fusion peptide 13CO to lipid 31P proximities support similar partially inserted membrane locations of the α helical and β sheet peptide structures.
    Gabrys CM; Qiang W; Sun Y; Xie L; Schmick SD; Weliky DP
    J Phys Chem A; 2013 Oct; 117(39):9848-59. PubMed ID: 23418890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fully hydrophobic HIV gp41 adopts a hemifusion-like conformation in phospholipid bilayers.
    Lee M; Morgan CA; Hong M
    J Biol Chem; 2019 Oct; 294(40):14732-14744. PubMed ID: 31409642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage.
    Nieva JL; Nir S; Muga A; Goñi FM; Wilschut J
    Biochemistry; 1994 Mar; 33(11):3201-9. PubMed ID: 8136355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The amino-terminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocyte membranes: peptide conformation, orientation and aggregation.
    Gordon LM; Curtain CC; Zhong YC; Kirkpatrick A; Mobley PW; Waring AJ
    Biochim Biophys Acta; 1992 Aug; 1139(4):257-74. PubMed ID: 1355364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidylcholine inhibits vesicles fusion induced by the NH2-terminal extremity of SIV/HIV fusogenic proteins.
    Martin I; Ruysschaert JM
    Biochim Biophys Acta; 1995 Nov; 1240(1):95-100. PubMed ID: 7495854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended.
    Korazim O; Sackett K; Shai Y
    J Mol Biol; 2006 Dec; 364(5):1103-17. PubMed ID: 17045292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of fusion peptides from HIV gp41 with membranes: a time-resolved membrane binding, lipid mixing, and structural study.
    Buzón V; Padrós E; Cladera J
    Biochemistry; 2005 Oct; 44(40):13354-64. PubMed ID: 16201760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both lipid environment and pH are critical for determining physiological solution structure of 3-D-conserved epitopes of the HIV-1 gp41-MPER peptide P1.
    Coutant J; Yu H; Clément MJ; Alfsen A; Toma F; Curmi PA; Bomsel M
    FASEB J; 2008 Dec; 22(12):4338-51. PubMed ID: 18776068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.